Therapeutic Asset Ratings

9,928 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Atrn-119 Myelodysplastic Syndrome	Washington University School of Medicine	P1	CC (43)
Atv-1601 Breast Disorder	Atavistik Bio, Inc	P1	CC (43)
Atv-1601 Cervical Cancer	Atavistik Bio, Inc	P1	CC (43)
Atv-1601 Cervical Carcinoma	Atavistik Bio, Inc	P1	CC (43)
Atv-1601 Uterine Cervix Neoplasm	Atavistik Bio, Inc	P1	CC (43)
Atv-1601 Endometrium Neoplasm	Atavistik Bio, Inc	P1	CC (43)
Atv-1601 Estrogen-Receptor Positive Breast Cancer	Atavistik Bio, Inc	P1	CC (43)
Atv-1601 Fallopian Tube Cancer	Atavistik Bio, Inc	P1	CC (43)
Atv-1601 Female Reproductive System Neoplasm	Atavistik Bio, Inc	P1	CC (43)
Atv-1601 Female Reproductive Organ Cancer	Atavistik Bio, Inc	P1	CC (43)
Atv-1601 Prostate Cancer	Atavistik Bio, Inc	P1	CC (43)
Atv-1601 Urinary System Neoplasm	Atavistik Bio, Inc	P1	CC (43)
Atv-1601 Tumor Of Uterus	Atavistik Bio, Inc	P1	CC (43)
Atx-295 Breast Cancer	Accent Therapeutics	P1	CC (43)
Atx-295 Ovarian Serous Adenocarcinoma	Accent Therapeutics	P1	CC (43)
Atx-559 Breast Cancer	Accent Therapeutics	P1	CC (43)
au409 Cholangiocarcinoma	University of Southern California	P1	CC (43)
aur106 Cancer	Aurigene Discovery Technologies Limited	P1	CC (43)
aur108 Lymphoma	Aurigene Discovery Technologies Limited	P1	CC (43)
aur112 Lymphoma	Aurigene Discovery Technologies Limited	P1	CC (43)
Autologous Anti-Cd19 Car-Expressing T Lymphocytes Adrenal Cortex Carcinoma	Anusha Kalbasi	P1	CC (43)
Autologous Anti-Cd19 Car-Expressing T Lymphocytes Paraganglioma	Anusha Kalbasi	P1	CC (43)
Autologous Anti-Cd19 Car-Expressing T Lymphocytes Cutaneous Melanoma	Anusha Kalbasi	P1	CC (43)
Autologous Anti-Cd19 Car-Expressing T Lymphocytes Pheochromocytoma	Anusha Kalbasi	P1	CC (43)
Autologous Anti-Cd19 Car-Expressing T-Lymphocytes Ic19/1563 B-Cell Non-Hodgkin Lymphoma	Mayo Clinic	P1	CC (43)

Showing 1026 to 1050 of 9,928 assets

PreviousPage 42 of 398Next